TheProfitWatch

ABOS - Acumen Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.55 0.03 (1.94%) 0.0 (0.0%) 0.01 (0.45%) 0.02 (1.28%) --- 0.03 (1.94%) --- ---

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.68
Diluted EPS:
-0.68
Basic P/E:
-2.3235
Diluted P/E:
-2.3235
RSI(14) 1m:
60.0
VWAP:
1.58
RVol:

Events

Period Kind Movement Occurred At

Related News